The Racing Medication and Testing Consortium (RMTC), which consists of 25 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing, will hold a special meeting of its Board on August 4 near Cincinnati, Ohio. The meeting follows the “International Summit on Race Day Medication, EIPH and the Racehorse,” held in June and co-hosted by the RMTC, American Association of Equine Practitioners (AAEP) and the National Thoroughbred Racing Association (NTRA).

At the August 4 meeting, the board will hear reports from committees that were formed in June to focus on the following topics:

• Penalty guidelines
• Proposals to phase out race day medication
• Enhanced stable area security and surveillance
• Guidelines for administration of race day medication

"In April, when we announced that we would be co-hosting an international medication summit with our colleagues at the AAEP and NTRA, we noted that we hoped to begin a process that had no pre-determined outcome. As a follow-up to the Summit, the RMTC has created several committees to develop the needed background information which will enable the full RMTC board to move expeditiously in developing specific recommendations relative to the various areas of focus identified at the Summit," said RMTC Chairman Dr. Robert Lewis.

About the RMTC: The RMTC works to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public. For additional information, visit the RMTC website at rmtcnet.com.